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Orexin is known as an important neuropeptide in the regulation of energy metabolism. However, the role
of orexin in exercise-induced leptin sensitivity in the hypothalamus has been unclear. In this study, we
determined the effect of transient treadmill exercise on leptin sensitivity in the mediobasal hypothala-
mus (MBH) of mice and examined the role of orexin in post-exercise leptin sensitivity. Treadmill running
for 45min increased the orexin neuron activity in mice. Intraperitoneal injection of a submaximal dose of
leptin after exercise stimulated the phosphorylation of signal transducer and activator of transcription 3
(STAT3) in MBH of mice post-exercise compared with that in non-exercised mice, although intra-
cerebroventricular (icv) injection of leptin did not enhance STAT3 phosphorylation, even after exercise.
Icv injection of an orexin receptor antagonist, SB334867 reduced STAT3 phosphorylation, which was
enhanced by icv injection of orexin but not by direct injection of orexin into MBH. Exercise increased the
phosphorylation of extracellular signal-regulated kinases (ERKs) in the MBH of mice, while ERK phos-
phorylation was reduced by SB334867. Leptin injection after exercise increased the leptin level in MBH,
whereas icv injection of SB334867 suppressed the increase in the leptin level in MBH of mice. These
results indicate that the activation of orexin neurons by exercise may contribute to the enhancement of
leptin sensitivity in MBH. This effect may be mediated by increased transportation of circulating leptin
into MBH, with the involvement of ERK phosphorylation.
© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The increasing number of obese people worldwide has created a
major social problem. For example, for diabetic patients with
obesity, medical expenses increase, and prognosis is poor [1].
Leptin is known to be secreted from adipose tissue, and it sup-
presses food intake and promotes energy metabolism via the hy-
pothalamus [2]. However, obese patients show an increase in the
blood leptin concentration and attenuation of the leptin effect [3,4].
This paradox is explained by leptin resistance. As a factor of thisxtracellular signal-regulated
toneal(ly); MBH, mediobasal
ve Physiology, Institute of
School, 3-18-15, Kuramoto,
uchi).
Inc. This is an open access article uphenomenon, mechanisms such as defects in leptin transport in
BBB, attenuation of phosphorylation of signal transducer and acti-
vator of transcription 3 (STAT3) in the MBH, loss and mutation of
LEP or LEPR gene have been proposed [5]. Leptin resistance leads to
further deterioration of obesity.
Chronic exercise improves leptin resistance as well as insulin
resistance [6e9]. It has been reported that 4-week exercise training
increased the expression of the leptin receptor, OB-Rb, in the
ventromedial hypothalamus (VMH) [10], which is an important site
in the MBH for leptin-induced glucose metabolism [11]. This
finding confirms that exercise can be an effective treatment for
metabolic diseases caused by leptin resistance. However, the effect
of transient exercise on leptin sensitivity and on the improvement
of leptin resistance in MBH is still unclear.
Orexin is a neuropeptide involved in pleiotropic functions such
as regulation of arousal, muscle tone, and locomotor activity
[12,13]. In addition, orexin is known to play an important role in the
regulation of energy metabolism. Orexin neuron deficiency causesnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
T. Shiuchi et al. / Biochemical and Biophysical Research Communications 514 (2019) 166e172 167not only narcolepsy and a decrease in food intake but also obesity in
mice [14]. In addition, there is also the knowledge that orexin drives
spontaneous activity [15]. Narcoleptic patients show an increase in
the body weight [16]. We have previously reported that orexin
regulates the skeletal muscle glucose metabolism via VMH [17],
which abundantly expresses the orexin type 1 receptor [18]. Since
exercise generally elevates the arousal level, we hypothesized that
exercise-activated orexin neurons and secreted orexin would syn-
ergistically enhance leptin sensitivity in MBH.
In this study, we determined the effect of transient treadmill
exercise on leptin sensitivity in MBH of mice and evaluated the role
of orexin in post-exercise leptin sensitivity in MBH using an icv
injection of an orexin receptor antagonist, SB334867.
2. Materials and methods
2.1. Animals
We used 16- to 24-week-old C57BL/6J male mice (Japan SLC,
Shizuoka, Japan). All mice were housed individually at a constant
room temperature of 23± 1 C with a 12-h light/dark cycle (lights
on at 8 a.m.) and were fed a standard non-purified diet (Oriental
Yeast, Tokyo, Japan) with food and water available ad libitum. All
experiments were approved by the Tokushima University Animal
Study Committee and conducted in accordance with the Guidelines
for the Care and Use of Animals approved by the Council of the
Physiological Society of Japan. All efforts were made to minimize
animal suffering and to reduce the number of animals used in the
experiments.
2.2. Treadmill running
Mice performed a transient treadmill running exercise (10m/
min, 45min) after habituation to treadmill running for 3 days
before the experiment. Only the mice that completed the endur-
ance running were used in this experiment.
2.3. Surgical operation on animals
Mice were anesthetized by intraperitoneal (ip) injection of ke-
tamine (100mg/kg) and xylazine (10mg/kg), and a double-walled
stainless steel cannula (Plastics One, Roanoke, VA, USA) was
implanted stereotaxically into bilateral MBH, whereas a stainless
steel cannulawas implanted unilaterally into the lateral ventricle of
the mice according to an atlas [19]. The stereotaxic coordinates for
MBH were AP 1.5 (1.5mm anterior to the bregma), L 0.3 (0.3mm
lateral to the bregma), and H 5.8 (5.8mm below the bregma). The
stereotaxic coordinates for lateral ventricle were AP 0.3, L 1.0, and H
2.4. The cannulas were anchored firmly to the skull with acrylic
dental cement.
2.4. Administration of orexin, SB334867 and leptin
Orexin-A (Peptide Institute, Osaka, Japan), dissolved in physio-
logical saline, was injected using a Hamilton microsyringe into
unrestrained mice through the unilateral cannula implanted into
the lateral ventricle (1 mL) or MBH (0.2 mL). The orexin type 1 re-
ceptor antagonist SB334867 (10mM) (Tocris Cookson, Bristol, UK)
was injected (1 mL) into the lateral ventricle. Mice received ip (2mg/
kg) or icv (1 mg) injection of leptin after running.
2.5. Western blotting
Forty-five minutes after leptin injection, MBHs were rapidly
isolated from cervically dislocated mice and stored at 80 C untilanalysis. The tissues were homogenized with cold lysis buffer, pH
7.5, containing protease inhibitors (P8370, SigmaeAldrich) and
phosphatase inhibitors (P5726, SigmaeAldrich). Protein was de-
natured by boiling in the loading buffer. Twenty micrograms of
proteins were subjected to sodium dodecyl sulfate polyacrylamide
gel electrophoresis and then transferred onto a polyvinylidene
difluoride membrane. The membranes were blocked with 5% skim
milk in Tris-buffered saline containing 0.05% Tween 20 for 1 h and
then incubated with rabbit antibodies (1:1,000; Cell Signaling
Technology, Dallas, TX, USA) against phospho-STAT3 (Tyr-705) and
STAT3. The blots were visualized with a horseradish peroxidase
(HRP)-conjugated anti-rabbit IgG secondary antibody (1:2,000;
Santa Cruz Biotechnology, Camarillo, CA, USA) and an Immobilon
western chemiluminescent HRP substrate (Millipore Corporation,
Billerica, MA, USA). The ImageJ software was used for the analysis.
2.6. Immunohistochemistry
This was following fixation in 4% paraformaldehyde in 0.1M
phosphate buffer before the brains were excised. The brains were
removed and post-fixed for 24 h. The fixed brain was incubated at
4 C for 2 days in phosphate-buffered saline (PBS) containing 20%
(w/v) sucrose. The tissue was then embedded in OCT compound
(Sakura FineTechnical, Tokyo, Japan), immediately frozen, and
stored at 80 C until analysis. Serial 30-mm cryosections were
prepared using a cryostat (CM1850; Leica, Wetzlar, Germany), with
the brain oriented for sectioning according to the mouse stereo-
taxic atlas [19]. Three sections corresponding to the lateral hypo-
thalamus (between 1.46 and 2.06mm posterior to the bregma)
or medial basal hypothalamus (between 1.46 and 1.70mm
posterior to the bregma) or median eminence (between 1.70
and 1.94mm posterior to the bregma) were selected per mouse.
For double immunohistofluorescence analysis of c-Fos and
orexin, brain sections were exposed to 3% normal donkey serum for
2 h at room temperature and then incubated for 3 days at 4 C with
goat antibodies against orexin (1:2,000 dilution; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and rabbit antibodies against
cFos (1:1,000 dilution; Cell Signaling Technology (CST), Danvers,
MA, USA). After washing the sections with PBS, immune complexes
were detected by incubation for 2 h at room temperature with an
Alexa Fluor-594-labeled donkey anti-goat IgG antibody (Molecular
Probes, Eugene, OR, USA) at a dilution of 1:500 or with an Alexa
Fluor-488-labeled donkey anti-rabbit IgG antibody (1:500; Molec-
ular Probes). The sections were finally examined under a micro-
scope (DM4000B; Leica) and carefully matched based on the shape
of brain structures. We counted co-expression sites of orexin and c-
Fos manually and calculated the co-expression rate in orexin
neurons.
Immunohistofluorescence analysis of ERK phosphorylation was
performed following the same protocol. We used a phospho-p44/
42 MAPK (Erk1/2) antibody (1:1,000 dilution; CST) as a primary
antibody and an Alexa Fluor-594-labeled donkey anti-rabbit IgG
(Molecular Probes) as a secondary antibody. The sections were
finally examined under a microscope (BZ-X700, Keyence, Osaka,
Japan).
To detect STAT3 phosphorylation, brain sections were quenched
for 10min with 3% H2O2 in methanol, then exposed to 3% normal
donkey serum for 2 h at room temperature and incubated over-
night at 4 C with a rabbit antibody to phospho-STAT3 (1:1,000
dilution; CST). After the sections were washed with PBS, immune
complexes were detected using a VECTASTAIN ABC HRP kit (rabbit
IgG; Vector Laboratories, Burlingame, CA, USA). The sections were
stained with a peroxidase stain DAB kit (Nacalai Tesque, Kyoto,
Japan) and metal enhancer for DAB stain (Nacalai Tesque) and
examined under a microscope.
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Leptin concentrations were measured in mouse MBH and
plasma samples using an ELISA kit (R&D Systems, Minneapolis, MN,
USA) according to the manufacturer's recommended protocols.
2.8. Statistical analysis
Results were expressed as the means± standard error of the
mean (SE). Data from two groupswere analyzed using the Student's
t-test. Data from more than two groups were analyzed using one-
way analysis of variance, followed by the Bonferroni test. P-values
of <0.05 were considered statistically significant.
3. Results
3.1. Exercise enhances leptin sensitivity via activation of orexin
neurons
We first examined whether transient treadmill running acti-
vates orexin neurons in mice. We made the mice run on a treadmill
for 45min, followed by 45min of rest, and then took brain samples
for immunohistochemical staining of orexin and c-Fos, which is a
marker for excitation in neurons [20]. Compared with the seden-
tary control, treadmill running significantly increased the ratio of c-
Fos-expressing orexin neurons to total orexin neurons (Fig. 1AeC).
This result demonstrated that transient aerobic exercise activated
orexin neurons in mice.
To examine leptin sensitivity in MBH after exercise, we injected
mice ip with a submaximal dose of leptin after treadmill running
and measured STAT3 phosphorylation in MBH of the mice using
western blotting (Fig. 1D). As shown in Fig. 1E, STAT3 phosphory-
lation in MBH was stimulated by ip injection of leptin but not by
exercise. The ip injection of leptin after exercise significantly
enhanced the phosphorylation of STAT3 in MBH, suggesting that
exercise may enhance leptin sensitivity in MBH.
Immunohistochemical staining showed that leptin-induced
STAT3 phosphorylation was enhanced after exercise not only in
the arcuate hypothalamus but also in VMH (Fig. 1FeI). Since the
orexin type 1 receptor is abundantly expressed in VMH [18], we
injected SB334867, an orexin type 1 receptor antagonist, into the
lateral ventricle of mice before treadmill running andmeasured the
STAT3 phosphorylation in MBH of the mice. The enhancement of
STAT3 phosphorylation by exercise and leptin was significantly
attenuated by icv injection of SB334867 before exercise. These re-
sults suggest that exercise-induced orexin enhances leptin sensi-
tivity in MBH of mice via the orexin type 1 receptor.
3.2. Orexin indirectly enhances STAT3 phosphorylation induced by
injection of leptin after exercise
We next determined whether orexin itself enhances leptin
sensitivity in MBH, even in the sedentary state. In this experiment,
we injected orexin into the lateral ventricle, and 45min later (same
as the treadmill running time), we injected leptin ip to the mice
(Fig. 2A). The icv injection of orexin did not stimulate STAT3
phosphorylation, but co-administration of leptin after orexin icv
injection significantly enhanced STAT3 phosphorylation in MBH
(Fig. 2B). We next evaluated whether orexin directly enhances
STAT3 phosphorylation in VMHwhere the orexin type 1 receptor is
abundantly expressed. Compared with contralateral injection of
saline to VMH, local unilateral injection of orexin to VMH sup-
pressed the leptin-induced STAT3 phosphorylation (Fig. 2C). These
results indicated that orexin indirectly enhances leptin sensitivity
in MBH.3.3. Exercise does not enhance leptin receptor signaling
To examine whether the exercise-induced enhancement of
leptin sensitivity in MBH depends on leptin receptor signaling, we
injected leptin into the lateral ventricle of mice after exercise
(Fig. 3A). The icv injection of leptin, with or without treadmill ex-
ercise, did not show a significant difference in STAT3 phosphory-
lation (Fig. 3B), suggesting that exercise does not enhance leptin
receptor signaling in MBH.
3.4. Orexin type 1 receptor is involved in exercise-induced leptin
transport into MBH associated with ERK phosphorylation
A recent study has demonstrated that ERK phosphorylation in
tanycytes of MBH, including themedian eminence (ME), is involved
in leptin transport through BBB [21]. We thus tried to detect a
difference in ERK phosphorylation in MBH of mice (Fig. 4A).
Immunohistochemical staining showed that the increase in ERK
phosphorylation by exercise was especially obvious in the arcuate
hypothalamus andME (Fig. 4BeE). Compared with control (Fig. 4B),
ERK phosphorylation was observed in the arcuate hypothalamus
and ME of the exercised leptin-injected mice but not in that of the
non-exercised leptin-injected mice (Fig. 4C and D). Moreover, icv
injection of SB334867 before treadmill running attenuated ERK
phosphorylation in the arcuate hypothalamus and ME of the mice
(Fig. 4E). Additionally, we confirmed that there was no effect on the
BBB permeability, which was measured by ip administration of
Evans blue (data not shown).
We finally examined whether leptin was transported into MBH
by exercise-induced activation of the orexin type 1 receptor. We
measured leptin concentrations in MBH and plasma after exercise.
The concentrations of leptin in MBH and plasma were significantly
increased by ip injection of leptin, although treadmill running had
no synergistic effect on leptin concentrations in MBH. In contrast,
icv injection of SB334867 diminished the increase in MBH leptin
after exercise, and significantly enhanced the increase of leptin in
plasma (Fig. 4F and G). On the other hand, the ratio between the
MBH and plasma leptin levels in exercised mice was significantly
higher than in non-exercised mice. Further, SB334867 injection
lowered the ratio of leptin levels in the MBH and plasma (Fig. 4H).
These results suggest that the orexin type 1 receptor is involved in
exercise-induced leptin transport into MBH associated with ERK
phosphorylation.
4. Discussion
Orexin-producing neurons abundantly exist in the lateral hy-
pothalamic field and are projected to almost all areas of the brain,
including VMH [12,22]. Previously, we have reported that orexin
injection into VMH stimulated the muscle glucose uptake via
sympathetic nerve activation. We thus thought that the orexin-
induced enhancement of leptin sensitivity in MBH after exercise
was a direct effect of orexin in MBH. However, direct injection of
orexin into MBH inhibited the enhancement of STAT3 phosphory-
lation by leptin after exercise. Orexin type 1 receptor signaling
activates themitogen-activated protein kinase pathway [23], which
negatively regulates leptin signaling. These findings suggest the
existence of a molecular mechanism through which orexin indi-
rectly enhances leptin sensitivity in MBH.
The cause of leptin resistance is the attenuated phosphorylation
of STAT3 in MBH, which is due to the impaired transit of peripheral
leptin across BBB and/or to impaired leptin signaling following
receptor binding [24,25]. To examine whether exercise enhances
leptin receptor signaling or BBB permeability for leptin, we injected
leptin in mice icv, with or without exercise, and observed similar
Fig. 1. Exercise enhances leptin sensitivity via activation of orexin neurons. Co-expression of orexin (red) and c-Fos (green) in the (A) sedentary group (n¼ 3) and (B) exercise group
(n¼ 3). Arrow head indicates c-Fos expressing orexin neuron. (C) Ratio of c-Fos-expressing orexin neurons to no c-Fos-expressing orexin neurons. The values shown are the
means ± SE. (D) Protocol used in this experiment. (E) Representative immunoblot phosphorylated or total STAT3 are shown above. Quantitative data are shown at bottom as bar
graph (n¼ 4). Representative immunohistochemical staining in phosphorylated STAT3 in (F) control, (G) leptin, (H) exercise and leptin, and (I) exercise, leptin, and SB334867
groups. Scale bars ¼ 200 mm. The values shown are the means ± SE. *P < 0.05 and **P < 0.01 vs. control. 3V: 3rd ventricle.
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exercised mice. Although we did not evaluate the activity of
negative regulators of leptin receptor signaling, such as suppressor
of cytokine signaling 3 and protein-tyrosine phosphatase 1B
[26e28], these results suggest that the leptin receptor signaling for
STAT3 might not contribute to the enhancement of leptin sensi-
tivity in MBH, associated with exercise.
Since circulating leptin cannot easily pass through BBB, a blood-to-brain transportation system is needed for leptin. As phosphor-
ylation of ERK in tanycytes, including ME, promotes hypothalamic
STAT3 phosphorylation by increasing the transportation of circu-
lating leptin into the brain [21], and orexin has been reported to
promote ERK phosphorylation [23], we speculated that activation
of orexin neurons by exercise might be involved in the enhance-
ment of ERK phosphorylation. In this study, icv injection of
SB334867 before exercise did not enhance the exercise-induced
Fig. 2. Orexin indirectly enhances STAT3 phosphorylation induced by leptin after exercise. (A) Protocol followed in the experiments. Effect of icv (B) or direct injection into MBH (C)
of orexin on STAT3 phosphorylation. Representative immunoblot of phosphorylated or total STAT3 are shown above. Quantitative data are shown at bottom as bar graph (n ¼ 4). The
values shown are the means ± SE. *P < 0.05 and **P < 0.01 vs. control.
Fig. 3. Central leptin did not affect STAT3 phosphorylation in MBH. (A) Protocol fol-
lowed in the experiments. (B) Representative immunoblot with phosphorylated or
total STAT3 is shown above. Quantitative data are shown at bottom as bar graph
(n ¼ 4). *P < 0.05 vs. control.
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confirmed that treadmill exercise did not alter the BBBpermeability. These results suggest that exercise-activated orexin
stimulates ERK phosphorylation in MBH.
We supposed that the exercise-induced phosphorylation of ERK
by orexin accelerates leptin transport into MBH. While leptin
concentrations were increased in MBH by ip administration of
leptin, icv injection of an orexin type 1 receptor antagonist signif-
icantly decreased the leptin concentration in MBH. However, leptin
levels in MBH were not enhanced by exercise after leptin admin-
istration, even though STAT3 phosphorylation was enhanced. On
the contrary, leptin levels tended to decrease in the plasma of
exercised mice compared with those of non-exercised mice,
although plasma leptin levels increased after ip administration of
leptin. As such, the ratio between leptin level in MBH and plasma in
leptin-injected groups were similar to the relative results with
STAT3 phosphorylation inMBH in the same groups. Leptin bound to
the long-form leptin receptor, OB-Rb, is internalized by endocytosis
and degraded in lysosomes [29,30]. Generally, exercise stimulates
the blood flow and decreases the plasma leptin level by inhibiting
leptin secretion from adipocytes [31,32]. Moreover, adrenaline
secreted during exercise stimulates leptin transport via a1-
adrenergic receptors [33]. We, therefore, think that the metabolic
turnover of leptin may increase in the whole body, leading to a
decrease in the excess leptin level in MBH of leptin-injected exer-
cised mice. A significant increase of the leptin level in the plasma
upon SB334867 administration supported this assumption because
leptin that was not transported into MBH could be accumulated in
circulation.
Exercise results in much energy consumption and exerts various
physiological effects on peripheral organs and the central nervous
system. Here, we found that exercise contributes to the enhance-
ment of leptin sensitivity in MBH. These data are important for
understanding the effect of exercise on the improvement of leptin
resistance in obese or diabetic patients.
Fig. 4. Orexin type 1 receptor is involved in exercise-induced leptin transport into MBH associated with ERK phosphorylation. (A) Protocol followed in the experiments. Repre-
sentative immunohistochemical staining in phosphorylated ERK expression in (B) control, (C) leptin, (D) exercise and leptin, and (E) exercise, leptin, and SB334867 groups. Scale
bars¼ 100 mm. Concentrations of leptin in MBH (F) and in plasma (G). (H) Ratio of leptin level in MBH and plasma (n ¼ 6). The values shown are the means ± SE. *P < 0.05 and
**P < 0.01 vs. control.
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